Abstract
Recent identification of four additional polyaminopathies, including Bachmann–Bupp syndrome, have benefited from previous research on Snyder–Robinson syndrome in order to advance from research to treatment more quickly. As a result of the discovery of these conditions, the potential for treatment within this pathway, and for other possible unidentified polyaminopathies, the International Center for Polyamine Disorders (ICPD) was created to help promote understanding of these conditions, research opportunities, and appropriate care for families. This case study provides insights from two new patients diagnosed with Bachmann–Bupp syndrome, further expanding our understanding of this ultra-rare condition, as well as a general discussion about other known polyaminopathies. This work also presents considerations for collaborative research efforts across these conditions, along with others that are likely to be identified in time, and outlines the role that the ICPD hopes to fill as more patients with these polyaminopathies continue to be identified and diagnosed.
| Original language | English |
|---|---|
| Article number | 29 |
| Journal | Medical sciences |
| Volume | 11 |
| Issue number | 2 |
| DOIs | |
| State | Published - Jun 2023 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2023 by the authors.
Keywords
- Bachmann–Bupp Syndrome (BABS)
- International Center for Polyamine Disorders (ICPD)
- Snyder–Robinson Syndrome (SRS)
- polyamine
- α-difluoromethylornithine (DFMO)
Fingerprint
Dive into the research topics of 'Two New Cases of Bachmann–Bupp Syndrome Identified through the International Center for Polyamine Disorders'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver